12/1
07:00 am
advm
Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly
Low
Report
Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly
11/19
06:18 pm
advm
Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights
11/19
02:10 pm
advm
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-HOUS, ADVM, HBAN, and COMP
Low
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-HOUS, ADVM, HBAN, and COMP
11/17
08:06 am
advm
Adverum Biotechnologies (NASDAQ:ADVM) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock, down previously from $30.00.
Low
Report
Adverum Biotechnologies (NASDAQ:ADVM) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock, down previously from $30.00.
11/7
08:28 am
advm
Shinobi Therapeutics Announces the Appointment of Dr. Laurent Fischer as Chair of its Board of Directors [Yahoo! Finance]
Low
Report
Shinobi Therapeutics Announces the Appointment of Dr. Laurent Fischer as Chair of its Board of Directors [Yahoo! Finance]
10/29
10:07 am
advm
Adverum Biotechnologies (NASDAQ:ADVM) was given a new $5.50 price target on by analysts at Mizuho.
Low
Report
Adverum Biotechnologies (NASDAQ:ADVM) was given a new $5.50 price target on by analysts at Mizuho.
10/28
12:00 pm
advm
Adverum Biotechnologies (NASDAQ:ADVM) was given a new $4.00 price target on by analysts at Royal Bank Of Canada.
Low
Report
Adverum Biotechnologies (NASDAQ:ADVM) was given a new $4.00 price target on by analysts at Royal Bank Of Canada.
10/28
10:59 am
advm
Adverum Biotechnologies (NASDAQ:ADVM) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Adverum Biotechnologies (NASDAQ:ADVM) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
10/28
06:18 am
advm
Adverum Biotechnologies (NASDAQ:ADVM) was downgraded by analysts at Chardan Capital from a "strong-buy" rating to a "hold" rating.
Medium
Report
Adverum Biotechnologies (NASDAQ:ADVM) was downgraded by analysts at Chardan Capital from a "strong-buy" rating to a "hold" rating.
10/28
06:18 am
advm
Adverum Biotechnologies (NASDAQ:ADVM) was downgraded by analysts at Truist Financial Corporation from a "strong-buy" rating to a "hold" rating.
Medium
Report
Adverum Biotechnologies (NASDAQ:ADVM) was downgraded by analysts at Truist Financial Corporation from a "strong-buy" rating to a "hold" rating.
10/27
01:01 pm
advm
HALPER SADEH LLC ENCOURAGES ADVM, PLYM, RNA SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Low
Report
HALPER SADEH LLC ENCOURAGES ADVM, PLYM, RNA SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
10/27
09:40 am
advm
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders
Medium
Report
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders
10/25
11:41 am
advm
Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. - ADVM
Medium
Report
Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. - ADVM
10/24
08:01 pm
advm
Adverum Biotechnologies (NASDAQ:ADVM) was given a new $5.00 price target on by analysts at Truist Financial Corporation.
Medium
Report
Adverum Biotechnologies (NASDAQ:ADVM) was given a new $5.00 price target on by analysts at Truist Financial Corporation.
10/24
05:30 pm
advm
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Adverum Biotechnologies, Inc. (NASDAQ: ADVM)
Medium
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Adverum Biotechnologies, Inc. (NASDAQ: ADVM)
10/24
02:57 pm
advm
Halper Sadeh LLC Encourages ADVM, MOFG, HSII Shareholders to Contact the Firm to Discuss Their Rights
Medium
Report
Halper Sadeh LLC Encourages ADVM, MOFG, HSII Shareholders to Contact the Firm to Discuss Their Rights
10/24
01:47 pm
advm
Shareholder Alert: The Ademi Firm investigates whether Adverum Biotechnologies, Inc. is obtaining a Fair Price for its Public Shareholders
Medium
Report
Shareholder Alert: The Ademi Firm investigates whether Adverum Biotechnologies, Inc. is obtaining a Fair Price for its Public Shareholders
10/24
09:39 am
advm
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. is Fair to Shareholders
Medium
Report
ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. is Fair to Shareholders
10/3
02:47 pm
advm
Adverum Biotechnologies (NASDAQ:ADVM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Adverum Biotechnologies (NASDAQ:ADVM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/3
06:38 am
advm
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners may be pleased with recent gains after 28% loss over the past year [Yahoo! Finance]
Low
Report
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners may be pleased with recent gains after 28% loss over the past year [Yahoo! Finance]
9/30
08:04 pm
advm
2 Penny Stocks That Wall Street Believes Can Soar Over 200% [Yahoo! Finance]
Medium
Report
2 Penny Stocks That Wall Street Believes Can Soar Over 200% [Yahoo! Finance]
9/23
08:07 am
advm
Adverum Biotechnologies (NASDAQ:ADVM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
High
Report
Adverum Biotechnologies (NASDAQ:ADVM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
9/22
08:43 am
advm
Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration [Yahoo! Finance]
High
Report
Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration [Yahoo! Finance]
9/22
08:00 am
advm
Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration
High
Report
Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration
9/21
06:58 pm
advm
Trexquant Slashes Stake in Adverum Biotechnologies, Inc. (ADVM) [Yahoo! Finance]
Medium
Report
Trexquant Slashes Stake in Adverum Biotechnologies, Inc. (ADVM) [Yahoo! Finance]